drug
M-002
Preclinicalupdated 3mo agoby M6P Therapeutics Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying M-002
- phase2Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
- phase1Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
- phase1A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that